The ground worth for the provide has been set at Rs 675 per fairness share which is at a reduction of 8.2% over as we speak’s closing worth of Rs 730.55 on the NSE.
The difficulty will open for non-retail buyers on September 10 and retail buyers will be capable to subscribe the shares on September 11.
Shares will probably be supplied solely in dematerialised type in accordance with OFS pointers, the corporate submitting issued to the exchanges mentioned.
Bansarilal’s stake within the firm stood at 68.99% as on June 30, 2025.
In regards to the OFS
The Supply will probably be carried out by way of a separate OFS window offered by NSE and BSE, with ICICI Securities, Kotak Securities, Motilal Oswal Monetary Providers, and Nomura Monetary Advisory & Securities (India) performing as the vendor’s brokers.
Blue Jet Healthcare is a world, science-led, pharmaceutical firm which advanced as a strategic associate for collaboration, improvement and manufacturing of superior pharmaceutical intermediates and API.
The OFS comes on the again of a rally of 40% over the past one 12 months. In 2025, the returns are to the tune of 27%.
Blue Jet’s share worth has been beneath stress over the past six months, declining almost 13% within the mentioned interval.
(Disclaimer: Suggestions, options, views and opinions given by the consultants are their very own. These don’t signify the views of Financial Instances)